Program By Day

7:00 AM-8:00 AM Complimentary Continental Breakfast
7:00 AM-6:30 PM Exhibits Open
7:55 AM-9:30 AM Welcome and General Session 4: Multimodality Management of Biliary Malignancies

Shishir Kumar Maithel, MD - Chair
Emory University School of Medicine

Ryan C. Fields, MD - Chair
Washington University School of Medicine in St Louis

TBD
Welcome of the Day

Juan W. Valle, MBChB, MSc, FRCP
The Christie NHS Foundation Trust
Current State of Adjuvant Therapy for Biliary Tract Malignancies

Robin Kate Kelley, MD
University of California, San Francisco
Advances in Molecular Targeted Therapies in Cholangiocarcinoma

Charles Rosen, MD
Mayo Clinic
Liver Transplantation for Cholangiocarcinoma: Indications and Outcomes

Panel Question and Answer
9:30 AM-10:00 AM Break
10:00 AM-11:30 AM General Session 5: Emerging Options for Hepatocellular Carcinoma—A Global Perspective

TBD - Chair

Riccardo Lencioni, MD - Chair
Sylvester Comprehensive Cancer Center

TBD
The Effect of New Anti-Viral Therapies for Hepatitis C on the Occurrence and Recurrence of Hepatocellular Carcinoma

Richard Kinh Gian Do, MD, PhD
Memorial Sloan Kettering Cancer Center
Diagnosis and Assessment of Response in Hepatocellular Carcinoma: Li-RADS, RECIST and mRECIST

Edward Kim, MD
Icahn School of Medicine at Mount Sinai
Locoregional Therapy with Selective Internal Radiotherapy for Hepatocellular Carcinoma: Where Do We Stand?

Jinsil Seong, MD, PhD
Yonsei University Medical College
Stereotactic Body Radiotherapy: What Role Does Focal Radiotherapy Play for Hepatocellular Carcinoma?

Ann-Lii Cheng, MD, PhD
National Taiwan University Hospital
Systemic Therapy for Advanced Hepatocellular Carcinoma

Panel Question and Answer
11:30 AM-1:00 PM Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
With Complimentary Boxed Lunch
11:30 AM-1:00 PM Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
With Complimentary Boxed Lunch
11:45 AM-12:30 PM Poster Walks
1:00 PM-2:00 PM Rapid Fire Abstract Session: Cancers of Pancreas, Small Bowel, and Hepatobiliary Tract
1:00 PM-2:00 PM Breakout Session: Hereditary Gastrointestinal Cancer Syndromes

TBD
Genetic Syndromes Associated With Increased Risk of Pancreaticobiliary and Gastroduodenal Cancers

TBD
Optimal Screening and Surveillance of Genetically High-Risk Individuals

TBD
Surgical Management of Cancers in Patients With a Genetic Predisposition

Panel Question and Answer
1:00 PM-2:00 PM Breakout Session: Minimally Invasive Diagnostic and Interventional Techniques for Pancreaticobiliary Malignancies

TBD
Technologic Advances in Endoscopic Visualization of Cancer

Christopher J. Dimaio
Icahn School of Medicine at Mount Sinai
Therapeutic Endoscopic Approaches to Pancreaticobiliary Tumors

Shailesh V. Shrikhande, MS, MD, FRCS
Tata Memorial Centre
Minimally Invasive Surgical Approaches: Current Evidence

Panel Question and Answer
2:00 PM-2:15 PM Break
2:15 PM-3:45 PM Oral Abstract Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
3:45 PM-4:15 PM Break
4:15 PM-5:30 PM General Session 6: Advanced and Metastatic Neuroendocrine Tumors (ARS)

Philip Agop Philip, MD, PhD, FRCP - Chair
Karmanos Cancer Institute

Michelle Kang Kim, MD, PhD - Chair
Icahn School of Medicine at Mount Sinai

Case 1: Synchronous Metastatic Midgut Neuroendocrine Tumor

Case 2: Gastric Neuroendocrine Tumor

Case 3: Unresectable Pancreatic Neuroendocrine

Massimo Falconi, MD
Ospedale San Raffaele
Surgeon Perspective

TBD
Endocrine/Oncology Perspective

TBD
Interventional Radiologist Perspective

Parag Parikh, MD
Washington University School of Medicine in St. Louis
Radiation Oncologist Perspective

Wolfgang Weber, MD
Memorial Sloan-Kettering Cancer Center
Nuclear Medicine Perspective
5:30 PM-6:30 PM Complimentary Wine and Cheese Reception